Ultragenyx Pharmaceutical
RARE
RARE
154 hedge funds and large institutions have $2.16B invested in Ultragenyx Pharmaceutical in 2017 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
15% less capital invested
Capital invested by funds: $2.56B → $2.16B (-$394M)
39% less call options, than puts
Call options by funds: $7.34M | Put options by funds: $11.9M
Holders
154
Holding in Top 10
1
Calls
$7.34M
Puts
$11.9M
Top Buyers
| 1 | +$27.7M | |
| 2 | +$14.1M | |
| 3 | +$12.4M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$10.4M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$8.59M |
Top Sellers
| 1 | -$58.2M | |
| 2 | -$14.9M | |
| 3 | -$13.8M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$11.4M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$7.96M |